Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine

Background: Asthma is one of the most common allergic diseases. Our previous studies have reported that FIP-fve in acute allergic mouse model can reduce inflammation, improve the balance of the Th1/Th2 system. However, the effects of reducing airway remodeling on FIP-fve is still unknown. Objective:...

Full description

Bibliographic Details
Main Authors: Yu-Tzu Lee, Chia-Ta Wu, Hai-Lun Sun, Jiunn-Liang Ko, Ko-Haung Lue
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:Journal of Microbiology, Immunology and Infection
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118217301214
id doaj-9bf319cf97424cf6a53e7c0765d2fd90
record_format Article
spelling doaj-9bf319cf97424cf6a53e7c0765d2fd902020-11-25T00:39:11ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822018-10-01515598607Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokineYu-Tzu Lee0Chia-Ta Wu1Hai-Lun Sun2Jiunn-Liang Ko3Ko-Haung Lue4Institute of Medicine, Chung Shan Medical University, Taichung, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Emergency Medicine, Changhua Christian Hospital, Changhua, TaiwanSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan; College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan; Corresponding author. Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chung Shan Medical University Hospital, No. 110, Sec. 1, Chien-Kuo N. Road, Taichung, 402, Taiwan. Fax: +886 4 2475 9950.Background: Asthma is one of the most common allergic diseases. Our previous studies have reported that FIP-fve in acute allergic mouse model can reduce inflammation, improve the balance of the Th1/Th2 system. However, the effects of reducing airway remodeling on FIP-fve is still unknown. Objective: We hypothesized that orally administrated FIP-fve should be able to reduce airway remodeling in chronic allergic models. Methods: The chronic asthma animal model was established with 6–8 weeks female Balb/c mice. After intranasal challenges with OVA, the airway inflammation and AHR were determined by a BUXCO system. BALF was analyzed with Liu's stain and ELISA assay. Lung histopathologic changes and Collagen deposition were assayed with H&E, Masson's trichrome and IHC stain. Results: FIP-fve significantly decreased the number of infiltrating inflammatory cells and Th2 cytokines and increased Th1 cytokines in BALF and serum compared with the OVA sensitized mice. FIP-fve had a better effect than corticosteroid could reduce infiltrating cells in lung especially neutrophils and eosinophils. We also found that the oral FIP-fve group suppressed IL-17 and enhanced IL-22 in the serum and BALF. In addition, oral FIP-fve decreased MMP9 expression, collagen expression and airway remodeling in lung tissues. Conclusion: FIP-fve had anti-inflammatory effects on OVA-induced airway inflammation and an effect to inhibited Th17 cells to reduced airway remodeling and collagen expression. Moreover, FIP-fve might be a potential alternative therapy for allergic airway diseases. Keywords: Asthma, Airway remodeling, Collagen deposition, FIP-fve, IL-17, IL-22http://www.sciencedirect.com/science/article/pii/S1684118217301214
collection DOAJ
language English
format Article
sources DOAJ
author Yu-Tzu Lee
Chia-Ta Wu
Hai-Lun Sun
Jiunn-Liang Ko
Ko-Haung Lue
spellingShingle Yu-Tzu Lee
Chia-Ta Wu
Hai-Lun Sun
Jiunn-Liang Ko
Ko-Haung Lue
Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
Journal of Microbiology, Immunology and Infection
author_facet Yu-Tzu Lee
Chia-Ta Wu
Hai-Lun Sun
Jiunn-Liang Ko
Ko-Haung Lue
author_sort Yu-Tzu Lee
title Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
title_short Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
title_full Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
title_fullStr Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
title_full_unstemmed Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
title_sort fungal immunomodulatory protein-fve could modulate airway remodel through by affect il17 cytokine
publisher Elsevier
series Journal of Microbiology, Immunology and Infection
issn 1684-1182
publishDate 2018-10-01
description Background: Asthma is one of the most common allergic diseases. Our previous studies have reported that FIP-fve in acute allergic mouse model can reduce inflammation, improve the balance of the Th1/Th2 system. However, the effects of reducing airway remodeling on FIP-fve is still unknown. Objective: We hypothesized that orally administrated FIP-fve should be able to reduce airway remodeling in chronic allergic models. Methods: The chronic asthma animal model was established with 6–8 weeks female Balb/c mice. After intranasal challenges with OVA, the airway inflammation and AHR were determined by a BUXCO system. BALF was analyzed with Liu's stain and ELISA assay. Lung histopathologic changes and Collagen deposition were assayed with H&E, Masson's trichrome and IHC stain. Results: FIP-fve significantly decreased the number of infiltrating inflammatory cells and Th2 cytokines and increased Th1 cytokines in BALF and serum compared with the OVA sensitized mice. FIP-fve had a better effect than corticosteroid could reduce infiltrating cells in lung especially neutrophils and eosinophils. We also found that the oral FIP-fve group suppressed IL-17 and enhanced IL-22 in the serum and BALF. In addition, oral FIP-fve decreased MMP9 expression, collagen expression and airway remodeling in lung tissues. Conclusion: FIP-fve had anti-inflammatory effects on OVA-induced airway inflammation and an effect to inhibited Th17 cells to reduced airway remodeling and collagen expression. Moreover, FIP-fve might be a potential alternative therapy for allergic airway diseases. Keywords: Asthma, Airway remodeling, Collagen deposition, FIP-fve, IL-17, IL-22
url http://www.sciencedirect.com/science/article/pii/S1684118217301214
work_keys_str_mv AT yutzulee fungalimmunomodulatoryproteinfvecouldmodulateairwayremodelthroughbyaffectil17cytokine
AT chiatawu fungalimmunomodulatoryproteinfvecouldmodulateairwayremodelthroughbyaffectil17cytokine
AT hailunsun fungalimmunomodulatoryproteinfvecouldmodulateairwayremodelthroughbyaffectil17cytokine
AT jiunnliangko fungalimmunomodulatoryproteinfvecouldmodulateairwayremodelthroughbyaffectil17cytokine
AT kohaunglue fungalimmunomodulatoryproteinfvecouldmodulateairwayremodelthroughbyaffectil17cytokine
_version_ 1725294757681299456